Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Patatin-like phospholipase domain-containing 10 pseudogene (PNPLA10P) is a member of the PNPLA family, which otherwise includes several active lipid hydrolase enzymes. PNPLA10P, however, is a pseudogene: a genetic locus that resembles a functional gene but is noncoding and believed to have no protein product or biological activity. Pseudogenes arise due to gene duplication or retrotransposition and typically lack regulatory elements or contain mutations preventing transcription or translation. As such, PNPLA10P should not be considered a drug target, nor does it have an established role in human disease, biomarker use, or drug interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Patatin-like phospholipase domain-containing 10 pseudogene (PNPLA10P).